EVOQ REMEDIES-MT share price
You have to be logged in to add this to Watchlist.EVOQ REMEDIES-MT is trading -% upper at Rs 7.33 as compared to its last closing price. EVOQ REMEDIES-MT has given -50.31% in this year & -5.91% in the last 5 days.
EVOQ REMEDIES-MT has TTM P/E ratio 27.63 as compared to the sector P/E of 33.29.
The company posted a net profit of 0.39 Crores in its last quarter.
Listed peers of EVOQ REMEDIES-MT include Emmessar Biotech & Nutrition (-1.76%), Norris Medicines (-2.26%), EVOQ REMEDIES-MT (-%) etc.
EVOQ REMEDIES-MT has a 88.79% public holding.
EVOQ REMEDIES-MT share price range
|
| ||||
|
| ||||
EVOQ REMEDIES-MT share Key Metrics
| Market Cap ( ₹ Cr.) | 18.25 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
EVOQ REMEDIES-MT Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 27-May-24 | Audited Results |
| 22-Jan-24 | Preferential issue of shares |
| 10-Nov-23 | Half Yearly Results |
| 08-Nov-23 | Half Yearly Results |
| 25-May-23 | Audited Results |
| 07-Nov-22 | Half Yearly Results & Rights issue |
| 30-May-22 | Audited Results |
| Meeting Date | Announcement On | Purpose |
| 28-Sep-24 | 17-Sep-24 | AGM |
| 28-Feb-24 | 06-Feb-24 | EGM |
| 30-Sep-23 | 11-Sep-23 | AGM |
| Announcement Date | Record Date | Ex-Rights Date | Ratio | FV | Description |
| 07-Nov-22 | - | - | 18:5 | 10 | Rights issue of equity shares of Rs. 10/- in the ratio of 18:5 @ par. |
FAQs about EVOQ REMEDIES-MT share price
EVOQ REMEDIES-MT is trading at 7.33 as on Mon Nov 25 2024 03:54:39. This is -% upper as compared to its previous closing price of 7.33.
The market capitalization of EVOQ REMEDIES-MT is 18.25 Cr as on Mon Nov 25 2024 03:54:39.
The 52 wk high for EVOQ REMEDIES-MT is 19.44 whereas the 52 wk low is 7.21
EVOQ REMEDIES-MT can be analyzed on the following key metrics -
- TTM P/E: 27.63
- Sector P/E: 33.29
- Dividend Yield: 0.00%
- D/E ratio: 0.17
EVOQ REMEDIES-MT reported a net profit of 0.45 Cr in 2024.
EVOQ REMEDIES-MT Quick Links
EVOQ REMEDIES-MT Dividend EVOQ REMEDIES-MT Bonus EVOQ REMEDIES-MT News EVOQ REMEDIES-MT AGM EVOQ REMEDIES-MT Rights EVOQ REMEDIES-MT Splits EVOQ REMEDIES-MT Board Meetings EVOQ REMEDIES-MT Key Metrics EVOQ REMEDIES-MT Shareholdings EVOQ REMEDIES-MT Profit Loss EVOQ REMEDIES-MT Balance Sheet EVOQ REMEDIES-MT Cashflow EVOQ REMEDIES-MT Q1 Results EVOQ REMEDIES-MT Q2 Results EVOQ REMEDIES-MT Q3 Results EVOQ REMEDIES-MT Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks